Abstract:Although p38 MAP Kinase α (p38 MAPKα) is generally accepted to play a central role in the cardiac stress response, to date its function in maladaptive cardiac hypertrophy is still not unambiguously defined. To induce a pathological type of cardiac hypertrophy we infused angiotensin II (AngII) for 2 days via osmotic mini pumps in control and tamoxifen-inducible, cardiomyocyte (CM)-specific p38 MAPKα KO mice (iCMp38αKO) and assessed cardiac function by echocardiography, complemented by transcriptomic, histological, and immune cell analysis. AngII treatment after inactivation of p38 MAPKα in CM results in left ventricular (LV) dilatation within 48 h (EDV: BL: 83.8 ± 22.5 μl, 48 h AngII: 109.7 ± 14.6 μl) and an ectopic lipid deposition in cardiomyocytes, reflecting a metabolic dysfunction in pressure overload (PO). This was accompanied by a concerted downregulation of transcripts for oxidative phosphorylation, TCA cycle, and fatty acid metabolism. Cardiac inflammation involving neutrophils, macrophages, B- and T-cells was significantly enhanced. Inhibition of adipose tissue lipolysis by the small molecule inhibitor of adipocytetriglyceride lipase (ATGL) Atglistatin reduced cardiac lipid accumulation by 70% and neutrophil infiltration by 30% and went along with an improved cardiac function. Direct targeting of neutrophils by means of anti Ly6G-antibody administration in vivo led to a reduced LV dilation in iCMp38αKO mice and an improved systolic function (EF: 39.27 ± 14%). Thus, adipose tissue lipolysis and CM lipid accumulation augmented cardiac inflammation in iCMp38αKO mice. Neutrophils, in particular, triggered the rapid left ventricular dilatation. We provide the first evidence that p38 MAPKα acts as an essential switch in cardiac adaptation to PO by mitigating metabolic dysfunction and inflammation. Moreover, we identified a heart–adipose tissue–immune cell crosstalk, which might serve as new therapeutic target in cardiac pathologies.

Noncanonical Camp Pathway and P38 MAPK Mediate Β2-Adrenergic Receptor-Induced IL-6 Production in Neonatal Mouse Cardiac Fibroblasts

β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts.

Time-dependence of Cardiomyocyte Differentiation Disturbed by Peroxisome Proliferator-Activated Receptor Α Inhibitor GW6471 in Murine Embryonic Stem Cells in Vitro

[Interleukin-1Beta Upregulates Matrix Metalloproteinase-2 Expression and Activity in Cardiac Fibroblasts Via Nitric Oxide Synthase Pathway].

β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes

AICAR Stimulates IL-6 Production Via P38 MAPK in Cardiac Fibroblasts in Adult Mice: a Possible Role for AMPK.

Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac fibroblasts.

A Novel Protein Kinase A-independent, Β-Arrestin-1-dependent Signaling Pathway for P38 Mitogen-activated Protein Kinase Activation by Β2-Adrenergic Receptors

Interleukin-6 Family of Cytokines Mediates Isoproterenol-induced Delayed STAT3 Activation in Mouse Heart

[Effects of Beta-Adrenoceptor Activation on Metabolism in Neonatal Rat Cardiomyocytes].

Phenylarsine Oxide Inhibited Β-Adrenergic Receptor-Mediated IL-6 Secretion: Inhibition of Camp Accumulation and CREB Activation in Cardiac Fibroblasts

[Expression of Beta2-Adrenergic Receptor and Its Effect on the Proliferation of Neonatal Rat Cardiac Fibroblasts].

β-adrenergic receptor activation promotes cardiac miR-21 expression by paracrine action of IL-6 from fibroblasts

Stimulation of Adenosine A2B Receptors Induces Interleukin‐6 Secretion in Cardiac Fibroblasts Via the PKC‐δ–P38 Signalling Pathway

THE MITOGEN-ACTIVATED PROTEIN KINASE p38 IS NECESSARY FOR INTERLEUKIN-1β-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN 1 EXPRESSION BY HUMAN MESANGIAL CELLS

[Isoproterenol-Induced Activation of MAPK, NFkappaB and JAK/STAT Pathway in Mouse Myocardium].

β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in Cardiomyocytes upon Increased Workload

Abstract 68: P38 MAP Kinase Regulates Chamber Specific Postnatal Remodelling of Cardiac Ventricles

Regulatory mechanisms underlying interleukin‐6 expression in murine brown adipocytes

Synthesis of the Ca2+-mobilizing messengers NAADP and cADPR by intracellular CD38 enzyme in the mouse heart: Role in β-adrenoceptor signaling

Cardiomyocyte p38 MAPKα suppresses a heart–adipose tissue–neutrophil crosstalk in heart failure development